4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-012780
Chief R&D Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Thackray Helen M. · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-31 | Grant or award : show line 1 in the form | +100,000 | 100,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-31 | Grant or award : show line 2 in the form Emp. Stock Option (Right to Buy) | +400,000 | 400,000 | D |
Loading xslF345X03/form4.xml…